Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gaugaz FZ"'
Autor:
Asmar V; Swedish Medical Products Agency, Uppsala, Sweden., Bergman E; Swedish Medical Products Agency, Uppsala, Sweden., Lindhagen E; Swedish Medical Products Agency, Uppsala, Sweden., Sherwood K; Swedish Medical Products Agency, Uppsala, Sweden., Westman G; Swedish Medical Products Agency, Uppsala, Sweden., Gaugaz FZ; Swedish Medical Products Agency, Uppsala, Sweden. fabienne.gaugaz@lakemedelsverket.se.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.
Autor:
Kölz C; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Gaugaz FZ; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Handin N; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Tremmel R; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Klein K; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Zanger UM; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Artursson P; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany., Nies AT; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2024 Nov; Vol. 181 (22), pp. 4593-4609. Date of Electronic Publication: 2024 Aug 02.
Autor:
Tremmel R; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Nies AT; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany.; iFIT Cluster of Excellence (EXC2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, 72076 Tuebingen, Germany., van Eijck BAC; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Handin N; Department of Pharmacy, Uppsala University, 75123 Uppsala, Sweden., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Büttner FA; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Kölz C; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Klein F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Mazzola P; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Hofmann U; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Klein K; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany., Hoffmann P; Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany.; Division of Medical Genetics, Department of Biomedicine, University of Basel, 4001 Basel, Switzerland., Nöthen MM; Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany.; Department of Genomics, Life & Brain Center, University of Bonn, 53127 Bonn, Germany., Gaugaz FZ; Department of Pharmacy, Uppsala University, 75123 Uppsala, Sweden., Artursson P; Department of Pharmacy, Uppsala University, 75123 Uppsala, Sweden., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany.; iFIT Cluster of Excellence (EXC2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, 72076 Tuebingen, Germany.; Departments of Clinical Pharmacology, and of Pharmacy and Biochemistry, University of Tuebingen, 72076 Tuebingen, Germany., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72076 Tuebingen, Germany.; iFIT Cluster of Excellence (EXC2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, 72076 Tuebingen, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 05; Vol. 23 (13). Date of Electronic Publication: 2022 Jul 05.
Autor:
Gaugaz FZ; ETH Zürich, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, 8093 Zürich, Switzerland. fabienne.gaugaz@gmx.net., Chicca A; Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland. andrea.chicca@ibmm.unibe.ch., Redondo-Horcajo M; Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, 28040 Madrid, Spain. horcajo@cib.csic.es., Barasoain I; Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, 28040 Madrid, Spain. i.barasoain@cib.csic.es., Díaz JF; Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, 28040 Madrid, Spain. fer@cib.csic.es., Altmann KH; ETH Zürich, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, 8093 Zürich, Switzerland. karl-heinz.altmann@pharma.ethz.ch.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2019 Mar 05; Vol. 20 (5). Date of Electronic Publication: 2019 Mar 05.
Autor:
Skogh A; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Lesniak A; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Sköld C; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Karlgren M; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Gaugaz FZ; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Svensson R; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Diwakarla S; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Jonsson A; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Fransson R; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Nyberg F; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Hallberg M; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Sandström A; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden; The Beijer Laboratory, Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden. Electronic address: anja.sandstrom@ilk.uu.se.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2018 Aug 01; Vol. 28 (14), pp. 2446-2450. Date of Electronic Publication: 2018 Jun 15.
Autor:
Skogh A; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Lesniak A; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Gaugaz FZ; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Svensson R; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Lindeberg G; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Fransson R; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Nyberg F; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Hallberg M; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Sandström A; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden. Electronic address: anja.sandstrom@orgfarm.uu.se.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2017 Nov 15; Vol. 109, pp. 533-540. Date of Electronic Publication: 2017 Sep 05.
Autor:
Wegler C; Department of Pharmacy, Uppsala University , Uppsala 75123, Sweden.; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D , Mölndal 431 50, Sweden., Gaugaz FZ; Department of Pharmacy, Uppsala University , Uppsala 75123, Sweden., Andersson TB; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D , Mölndal 431 50, Sweden., Wiśniewski JR; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry , Martinsried 82152, Germany., Busch D; Center of Drug Absorption and Transport, Department of Clinical Pharmacology, University Medicine of Greifswald , Greifswald 17489, Germany., Gröer C; Center of Drug Absorption and Transport, Department of Clinical Pharmacology, University Medicine of Greifswald , Greifswald 17489, Germany., Oswald S; Center of Drug Absorption and Transport, Department of Clinical Pharmacology, University Medicine of Greifswald , Greifswald 17489, Germany., Norén A; Department of Surgical Sciences, Uppsala University , Uppsala 75185, Sweden., Weiss F; NMI Natural and Medical Sciences Institute, University of Tübingen , Reutlingen 72770, Germany., Hammer HS; NMI Natural and Medical Sciences Institute, University of Tübingen , Reutlingen 72770, Germany., Joos TO; NMI Natural and Medical Sciences Institute, University of Tübingen , Reutlingen 72770, Germany., Poetz O; NMI Natural and Medical Sciences Institute, University of Tübingen , Reutlingen 72770, Germany., Achour B; Centre for Applied Pharmacokinetic Research, University of Manchester , Manchester M13 9PL, United Kingdom., Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, University of Manchester , Manchester M13 9PL, United Kingdom., van de Steeg E; TNO (Netherlands Organization for Applied Scientific Research) , 3700 AJ Zeist, Netherlands., Wortelboer HM; TNO (Netherlands Organization for Applied Scientific Research) , 3700 AJ Zeist, Netherlands., Artursson P; Department of Pharmacy, Uppsala University , Uppsala 75123, Sweden.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2017 Sep 05; Vol. 14 (9), pp. 3142-3151. Date of Electronic Publication: 2017 Aug 16.
Autor:
Skogh A; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Lesniak A; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Gaugaz FZ; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Svensson R; Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Science for Life Laboratory Drug Discovery and Development Platform, Department of Pharmacy, Uppsala University, BMC, Box 580, SE-751 23 Uppsala, Sweden., Lindeberg G; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Fransson R; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden., Nyberg F; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Hallberg M; The Beijer Laboratory, Department of Pharmaceutical Bioscience, Uppsala University, BMC, Box 591, SE-751 24 Uppsala, Sweden., Sandström A; Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23 Uppsala, Sweden. Electronic address: anja.sandstrom@orgfarm.uu.se.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2017 Aug 30; Vol. 106, pp. 345-351. Date of Electronic Publication: 2017 Jun 03.
Autor:
Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Ström CE, Svensson LM, Schultz N, Lundbäck T, Einarsdottir BO, Saleh A, Göktürk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Strömberg K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ, Loseva O, Bräutigam L, Johansson L, Höglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S, Evers B, Henriksson M, Vallin KSA, Wallner OA, Hammarström LGJ, Wiita E, Almlöf I, Kalderén C, Axelsson H, Djureinovic T, Carreras Puigvert J, Häggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I, Jenmalm Jensen A, Artursson P, Nilsson JA, Stenmark P, Scobie M
Publikováno v:
Nature [Nature] 2017 Apr 26; Vol. 544 (7651), pp. 508.
Autor:
Warpman Berglund U; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Sanjiv K; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Gad H; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Kalderén C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Koolmeister T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Pham T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Gokturk C; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Jafari R; Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology., Maddalo G; Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology., Seashore-Ludlow B; Chemical Biology Consortium Sweden, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Chernobrovkin A; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Manoilov A; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Pateras IS; Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Rasti A; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Jemth AS; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Almlöf I; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Loseva O; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Visnes T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Einarsdottir BO; Sahlgrenska Translational Melanoma Group (SATMEG), Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg., Gaugaz FZ; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics.; Department of Pharmacy and., Saleh A; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden., Platzack B; Swedish Toxicology Sciences Research Center, Södertälje, Sweden., Wallner OA; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Vallin KS; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Henriksson M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Wakchaure P; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Borhade S; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Herr P; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Kallberg Y; National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm., Baranczewski P; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics.; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden., Homan EJ; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Wiita E; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Nagpal V; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics.; SP Process Development, Södertälje, Sweden., Meijer T; SP Process Development, Södertälje, Sweden., Schipper N; SP Process Development, Södertälje, Sweden., Rudd SG; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Bräutigam L; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Lindqvist A; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden., Filppula A; Uppsala Drug Optimisation and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden., Lee TC; Institute of biomedical sciences, Academia Sinica, Taipei-115, Taiwan., Artursson P; Department of Pharmacy and.; Science for Life Laboratory Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Phamracy, Uppsala University, Uppsala, Sweden.; Uppsala Drug Optimisation and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden., Nilsson JA; Sahlgrenska Translational Melanoma Group (SATMEG), Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg., Gorgoulis VG; Biomedical Research Foundation of the Academy of Athens, Athens, Greece.; Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK., Lehtiö J; Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology., Zubarev RA; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Scobie M; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics., Helleday T; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics thomas.helleday@scilifelab.se.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Dec; Vol. 27 (12), pp. 2275-2283. Date of Electronic Publication: 2016 Nov 08.